Faculty
Anne O. Summers
Professor of Microbiology
Ph.D. (1973) Washington University
Address: Department of Microbiology
263A Biological Sciences Building
Athens, GA 30602-2605
Phone: (706)
542-2669
E-mail: summers@uga.edu
COS CV: http://myprofile.cos.com/summersa70
PubMed: summers ao
Research Interests:
Though some metals are essential for life others,
such as mercury (Hg), are toxic. Bacteria have evolved a detoxification
system, the Hg resistance (mer) operon, often found on bacterial
plasmids which also carry antibiotic resistance genes. We study
the mechanism of Hg resistance and the co-evolution of metal
and antibiotic resistance plasmids in the commensal microbiota
of humans and animals. Collaborating with enzymologist Sue Miller
at UCSF, we are determining the role of a small metallochaperone
domain in the key Hg-detoxification enzyme, MerA (mercuric reductase).
We are also dissecting the mechanism of MerB (organomercurial
lyase) and determining its 3D structure with UGA crystallographer,
Cory Momany. The Hg-binding domain of the metalloregulator, MerR,
which controls expression of the mer operon (merTPCABD) lies
in a novel anti-parallel coiled-coil structure. MerR also captures
RNA polymerase (RNAP) in a unique, pre-initiation complex at
the mer promoter. We have identified the sub-domains of MerR
involved in interactions with RNAP and are now determining the
mechanistic basis of MerR's metal affinity and specificity. Hg
resistant bacteria are unusually abundant in the commensal intestinal
and oral microbiota. They are also typically multiple antibiotic
resistant since Hg and antibiotic resistance genes are genetically
linked on conjugative plasmids. Using microarrays we have found
Hg exposure significantly alters the composition of the commensal
ecosystem. In related work, we've also found an unexpected reservoir
of multi-resistant integrons in the commercial poultry production
ecosystem. What we learn will provide tools for ameliorating
metal pollution and intoxication and will enable a longer usable
lifetime for new and existing antibiotics.
